Skip to main content
Egyptian Liver Journal

Table 6 Correlations between the Resistin Pre-treatment and all other parameters in the study in both groups of patients

From: Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

Correlations

 

Resistin Pre

Naive

Relapser

r

P-value

r

P-value

Age(years)

0.224

0.343

-0.109

0.646

BMI(kg/m2)

0.232

0.325

-0.186

0.432

ALT(IU/L)

-0.207

0.382

0.245

0.298

AST(IU/L)

-0.118

0.621

0.157

0.509

Alb(g/dL)

-0.054

0.822

-0.116

0.627

Bil(mg/dL)

0.232

0.325

-0.039

0.870

Hb(g/dL)

-0.087

0.717

-0.187

0.429

TLC(×103/μL)

-0.146

0.538

-0.259

0.271

Plat(×103/μL)

0.040

0.866

-0.033

0.889

INR

-0.234

0.321

0.445

0.050

FBS Pre(mg/dL)

0.695

<0.001*

0.054

0.822

Fast Insulin Pre(μU/ml)

0.756

<0.001*

0.725

<0.001*

HOMA

0.494

0.027*

0.510

0.021*

PCR(IU/mL)

-0.026

0.913

-0.047

0.843

AFP(ng/mL)

-0.099

0.677

0.030

0.900

FIB4

0.160

0.499

0.054

0.821

  1. This table shows a significant positive correlation between Pre-treatment Resistin and ‘Fasting Insulin and HOMA-IR’ among Naïve & Relapser Patient and ‘FBS in Naïve patients only’ with insignificant correlation with all other parameters
Back to article page